Abstract. Hepatitis C-Associated Osteosclerosis (HCAO) is characterized by a marked increase in bone mass with deep bone pain. Since 1992, eleven cases of HCAO have been reported. This report describes an elderly Japanese man with HCAO, whose clinical course we followed for 3 years. A 68-year-old man developed pain in both pretibial regions in June 2000, and he had frequent episodic loss of muscular strength in his hands. He had recieved blood transfusion for a bleeding ulcer 43 years before and was seropositive for hepatitis C virus. His serum alkaline phosphatase (ALP) level was markedly increased, while his serum calcium was slightly decreased and serum phosphate was normal. Skeletal radiographs of the lower extremities showed a progressive increase in skeletal density, but did not show any apparent deformity. Administration of nonsteroidal anti-inflammatory drugs led to a reduction in bone pain. Treatment with vitamin D3 and calcium decreased the number of episodes of sudden muscular weakness and maintained serum calcium within the normal range. Three years after the onset of the disease, bone mineral density of his lumbar vertebrae and left hip rose from 0.963 g/cm 2 to 1.096 g/cm 2 , and from 0.938 g/cm 2 to 1.383 g/cm 2 , respectively. His serum ALP level decreased from 2889 to 277 IU/L (normal range: 104-338) and serum calcium normalized. These findings were accompanied by a decrease in bone pain. This case and previous reports suggest that the skeletal tissue of this disease appears to be of good quality.
HEPATITIS C-Associated Osteosclerosis (HCAO) is characterized by a generalized increase in bone mass in adults who are infected with hepatitis C virus (HCV). Since 1992, twelve cases of HCAO have been reported [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] . All showed increased bone density with deep bone pain, associated with elevated serum alkaline phosphatase (ALP). To our knowledge, this case is the 13th patient reported with HCAO. No longitudinal clinical information has been available for the previous case reports. This report describes an elderly Japanese man with HCAO, whose clinical course we followed for a period of 3 years.
Case Report
A 68-year-old Japanese man was generally in good health until June 2000, when he developed pain first in the bilateral pretibial regions and later in the thighs. Pain associated with anorexia and sleeplessness gradually became more severe and eventually he was only able to walk short distances. Thereafter, he periodically developed a sudden weakness in the hands when holding an object such as a coffee cup. When he was evaluated at a local hospital in May 2000, the serum ALP level was extremely elevated (1664 IU/L; normal range: 104-338) while serum calcium was rather low (7.8 mg/dl; normal range: 8.7-11.0). To search for a focus of inflammation, they performed Gallium-67 whole body scan (Fig. 1) , which showed enhanced diffuse uptake of radioactivity in all major long bones, especially the lower extremities. He was referred to our hospital for further examination.
In 1957, the patient had recieved a blood transfusion for a bleeding gastric ulcer. In 1993, his serum transaminase levels were elevated, and he was found to be seropositive for HCV antibody. At that time, he refused interferon therapy for chronic hepatitis C. Transaminase levels fluctuated over the reference range. However, he had never become jaundiced. There was no history of intravenous drug abuse, tattoos, acupuncture, exposure to heavy metals, excess vitamin ingestion or malabsorption. Renal function was normal. There was no family history of bone disorders. Neither of his parents or four siblings had history of any bone abnormality. He has no children.
Physical examinations demonstrated a wellnourished man, whose height was 171 cm and weight 72 kg. His blood pressure was 124/72 mmHg, and pulse rate was 68 beats/min. There was no organomegaly or lymphadenopathy. Neuromuscular and articular examinations were normal. The only remarkable physical finding was tenderness on palpation or gentle compression of the long bones, especially in the anterior tibiae. He presented without heat, redness or swelling of the legs. There was no tenderness over the skull, ribs, pelvis or spine. He had no skeletal deformities. Dentition was normal and there was no auditory symptom.
Serum creatinine level was 0.7 mg/dl (normal range: 0.5-1.1), alanine transaminase (ALT) 121 U/L (normal Bone-specific ALP level was increased to 9 times the upper limit of the reference range while osteocalcin was increased to approximately 4 times. Increased serum ALP and osteocalcin levels reflected enhanced bone formation and bone resorption was also increased, as indicated by the elevated urinary deoxypyridinoline excretion rate. This indicated accelerated skeletal remodeling. HCV antibody, determined by immunoassay, was positive. HCV ribonucleic acid was detected by the Chiron branched DNA assay (2.0 mEq/mL; normal, <0.02). Ultrasound study of the abdomen showed typical patterns of chronic hepatitis and a liver biopsy specimen demonstrated active chronic hepatitis. Radiographs of the long bones of the legs and pelvis showed an increase in skeletal density. There was a progressive increase in the width of cortices from the time of the patient's initial evaluation in 2000 ( Fig. 2A, 2B ) through 2003 (Fig. 2C, 2D) . Radiographs of the hands and skull were normal. There was no focal sclerosis, pseudo-fracture or deformity. Table 3 shows bone cellular and kinetic indices. Iliac crest bone biopsy (September, 2000) after doubletetracycline labeling (labeling interval of 10 days) demonstrated a significant increase in indices of bone formation and resorption, although the bone was of a normal lamellar pattern (Fig. 3A) . Separation of tetracycline lines evidently increased (Fig. 3B) . The surface extent of osteoclasts, osteoblasts and osteoids was high. The parameters of bone volume, osteoid volume and eroded surface were all elevated. Most importantly, bone formation rate (BFR, using BS and BV as referents) greatly increased.
Clinical course
Administration of non-steroidal anti-inflammatory drugs (NSAIDs) led to reduction in bone pain. Be- (Fig. 4) . In April 2002, the patient reported that the leg pain had become less severe compared to that at initial evaluation. By April 2003, leg pain was resolved.
At the time of his initial evaluation (November 2000), bone mineral density (BMD) performed on dual energy radiography (Hologic QDR 2000, Waltham, MA, USA) was low normal for a man of his age. Three years after the initial study, BMD of the left hip rose from 0.938 g/cm 2 to 1.383 g/cm 2 , a level higher than the mean peak bone mass of a young man (T score: + 3.16). Lumbar vertebrae and whole body BMDs also increased. The rate of change/yr of whole body BMD was +0.1330 g/cm 2 yr (% change/yr was +12.1%) ( Table 4) . Discussion HCAO is a rare disorder, characterized by a generalized increase in bone mass in adults who are infected with HCV. Our present case corresponds to previously reported cases of HCAO, whose age ranged from 27 to 73. One man was African-American and one woman was Japanese while the other patients were Caucasian.
Nine patients were from the United States and one from Australia and one from Italy and two from Japan. In our case, the patient had never traveled outside of Japan. This indicates that the cause is not geographically distinct. Contamination with illegal drugs or infectious agents from shared needles was initially considered the cause of this disease [2, 3, [5] [6] [7] . To date, three cases, including our patient, have now been described as having definitely acquired HCV infection from blood transfusion without a history of intravenous drug abuse [1, 9] . All of the reported cases were infected with HCV, which might be responsible for the etiology of HCAO. Our report lends further support to this hypothesis.
There can be a long latency between HCV infection and the development of skeletal abnormalities. Previous cases have reported that bone pain occurred 8 to 12 years after a blood transfusion [1, 9] . Our patient certainly acquired HCV infection from a transfusion 43 years ago. The prevalence of HCV antibody among blood donors in Japan is about 0.6% in the general population, but increases with age, reaching 2% in the fifth and sixth decades of life [13] . However, HCAO is thought to be rare among HCV seropositive patients, because randomized skeletal radiographs of 107 HCV patients failed to show any evident osteosclerosis [14] . It is still possible that the mild type of this disease might be discovered by biochemical parameters reflecting bone formation. There are several explanations for the etiology of HCAO. First, HCV itself may directly infect bone cells or osteoprogenitor cells, activating osteoblasts and bone accretion. Retroviruses are known to activate osteoblasts and cause osteosclerosis in chickens and mice [14] . Second, other infective agents transmitted with HCV may trigger this disease. Third, HCV within the liver or other tissues may produce cytokines or growth factors stimulating bone formation. Khosla et al. reported that IGF-binding protein-2 might be a potential candidate for mediating the increase in osteoblastic activity [15] . Bone densitometry was performed using dual energy radiography (Hologic QDR 2000, waltham, MA, USA). * Standard division from mean of young adult population. Of considerable interest is the diffusely increased skeletal mass of these patients. Skeletal radiographs show generalized cortical thickening. Skeletal scintigraphy demonstrates diffusely increased uptake of radiolabeled agents, but does not show focal defects. Bone density gradually increases over a period of several years. Despite the remarkable increase in bone mass, patients do not demonstrate cranial nerve compressions such as facial palsy, deafness, visual problems or marrow compromise, which can be complications of osteopetrosis. Transiliac bone biopsy with tetracycline labeling shows not only increased bone formation rates, but good quality with intact lamellar patterns of osseous tissue. Abnormal remodeling with woven bone is often found in Paget's disease of the bone [14] . The quality of the sclerotic bone does not appear abnormal in this disease. There are no reports of bone deformity or fracture. Previous case reports are summarized in Table 5 .
Markers of bone formation, such as ALP and osteocalcin, were increased in all reported patients. Markers of bone resorption such as urinary deoxypyridinorine and hydroxyproline also increased. Serum calcium and phosphorous were normal but urinary calcium excretion was decreased. However, in our patient, hypocalcemia was repeatedly found. Mild hypocalcemia and hypocalciuria likely resulted from the flux of calcium into the skeleton due to rapid bone formation. The serum PTH level and 1,25-hydroxyvitamine D level increased. Findings lead researchers consider to believe that mild hyperparathyroidism apparently results from skeletal hyperaccretion of calcium. The elevated 1,25-dihydroxyvitamin D level might be due to stimulation of 25-hydroxyvitamin D 1α hydroxylase by PTH.
The chief complaint of patients with this disease is severe bone pain. Bone pain is likely related to increased bone formation at the periosteum. In our case, the administration of NSAIDs resulted in a reduction in pain and calcium and vitamin D3 led to symptomatic improvement in muscular weakness. Other treatments such as calcitonin injections or pamidronate infusions have been reported, but responsiveness to pharmacological treatments have varied [2, 4, 7, 10] . The disease spontaneously remits in several years and the pain resolves. Reduction in bone turn over might improve the symptoms. Over several years, the serum ALP level and the other markers of bone formation normalize, and these biochemical changes are accompanied by a resolution of bone pain. In our case, serum transaminase levels returned to the normal range after the patient became free of pain. Pain and biochemical abnormalities in this disease spontaneously remitted after several years. The precise pathogenesis of HCAO is unknown. This case as well as the previous reports suggest that osteosclerosis of this disease appears to have a good prognosis.
